No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Sleep Apnea is a disorder characterized by pauses in breathing during sleep. It is a common disorder, affecting millions of people worldwide. Treatment for Sleep Apnea typically involves lifestyle changes, such as avoiding alcohol and sleeping on one's side, as well as the use of respiratory drugs.
Respiratory drugs are used to treat a variety of conditions, including Sleep Apnea. These drugs can be divided into two categories: central nervous system (CNS) depressants and stimulants. CNS depressants, such as benzodiazepines, are used to reduce the activity of the central nervous system and can help reduce the severity of Sleep Apnea. Stimulants, such as methylphenidate, are used to increase the activity of the central nervous system and can help improve breathing during sleep.
The Sleep Apnea Drug market is a subset of the larger Respiratory Drug market. It includes drugs used to treat Sleep Apnea, as well as devices and other treatments. Companies in this market include GlaxoSmithKline, Merck, Pfizer, and Sanofi. Show Less Read more
